Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.

Ziying ZhangPeng ChenHui XiePeiguo Cao

Published in: Cancer medicine (2019)

Circulating tumor DNA displays a promising diagnostic potential in HCC. However, it is not independently sufficient and can serve as an assistant tool combined with AFP for HCC screening and detection.

Keyphrases

circulating tumor
cell free
circulating tumor cells
high throughput
loop mediated isothermal amplification
human health
risk assessment
sensitive detection